Abstract
A novel synthesis of the potent glutamate neurotransmitter agonist (RS)-2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl) propionic acid (ACPA) provides access to numerous analogues as drug candidates for neurological disorders. The one-pot synthesis of an alpha amino phosphonate from aldehyde 4 was successful using ErCl3 as a catalyst. Molecular modeling of the new amino phosphonic acid with the (RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl) propionic acid (AMPA) receptor crystal structure suggests this should be an effective receptor binder.
| Original language | English |
|---|---|
| Pages (from-to) | 8415-8418 |
| Number of pages | 4 |
| Journal | Tetrahedron Letters |
| Volume | 42 |
| Issue number | 48 |
| DOIs | |
| State | Published - Nov 26 2001 |
Funding
Financial support of this research from the National Institute of Neurological Disorders and Stroke (Grant NS38444-01) is gratefully acknowledged. We thank Dr. Gary Knerr, Dr. Alex Blumenfeld, and Dr. Andrzej Paszczysnki for their spectroscopic contributions. We acknowledge Dr. Eric Gouaux for helpful discussions concerning the AMPA receptor ligand binding domain.
| Funder number |
|---|
| NS38444-01 |
Keywords
- AMPA
- Glutamate
- Isoxazole
Fingerprint
Dive into the research topics of 'A new direct synthesis of ACPA and novel AMPA analogues'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver